Sublime

An inspiration engine for ideas

AllPeopleCollectionsArticlesAudioBooksFilesHighlightsImagesLinksNotesTextTweetsVideosSocial

Thumbnail of www-x-com-dgrouf-status-1806923478102093869-5593159b6d9d4a96

The Grouf Cancer Protocol (for research purposes only)- Revised, updated https://t.co/t4qIKrDekn

Dr. Grouf

x.com

PSA: Thanks to Roche/Genentech and Amgen scientists, these 2 papers have probably the most extensive immunogenicity (ADA%) for approved antibodies. https://t.co/RUezUIJayj https://t.co/GUDBpAiXsR https://t.co/VzoQ3I2q1c

Jing Liang 🇺🇦

x.com

I am recruiting: Principal Research Physician at Protas, our new not-for-profit organization focused on Smarter Randomized Trials for Better Public Health - provide expert scientific & clinical leadership - deliver major impact on clinical... See more

Martin Landray x.com

.@PhaseGenomics just got $5.5M from @gatesfoundation & @NIH to catalog the viruses that infect bacteria. The resulting database could be used to develop new therapeutics & build a surveillance system to detect & respond to microbial threats. https://t.co/QBkX3XD2TF #biotech

GeekWire x.com

Who are biostatisticians/theoretical epidemiologists working on COVID/ infectious disease research? #epitwitter

Manjari Narayan x.com

Mount Sinai is going to start treating patients using antibodies from recovered ones. https://t.co/bAzrk3oscf

Paul Graham x.com

Supplements

elandi84 • 1 card

SOS microbios: Cómo nuestro abuso de los antibióticos aviva las plagas modernas (Spanish Edition)

Martin J. Blaser

amazon.com

Cover of SOS microbios: Cómo nuestro abuso de los antibióticos aviva las plagas modernas (Spanish Edition)

Antibiotics, a staple of modern medicine, are at risk from ⬆️ resistance. In addition to #antibiotic stewardship, developing new antibiotics is a key defense in the battle against ever-adapting microbes. But how can we ensure antibiotic innovation? A🧪New Working Paper🧪below 👇: https://t.co/xHlDbJcTWH

Ed Kong

x.com